Imperial College Healthcare Nhs Trust

Cepheid partners with Fleming Initiative to combat antimicrobial resistance (AMR), focusing on accurate diagnostics and responsible antibiotic use. The collaboration aims to address AMR through active screening, community-based testing, and precision medicine for sepsis.

Moderna's mRNA-4359 vaccine, targeting advanced melanoma and solid tumours, shows potential in early trials, with 8 out of 16 patients experiencing no tumour growth. The treatment, using mRNA tech similar to COVID-19 vaccines, primes the immune system to recognize and fight cancer cells, with no serious side effects reported. The results, to be presented at a European oncology conference, mark an important step towards a new cancer treatment.

The SepTiC study aims to improve sepsis treatment by answering three key questions: the efficacy of rapid PCR testing for targeted antibiotics, the impact of fluid reduction on patient recovery, and the potential benefits of immune-boosting medication. Funded by the NIHR, the study is currently recruiting patients across multiple UK hospitals.

AI and automation are transforming healthcare work, focusing on augmenting rather than replacing jobs. Technologies can substitute, supersede, support, or strengthen tasks, enabling staff to focus on higher-value activities. A proactive approach, involving staff in technology development and adapting roles, is crucial for leveraging technology to improve healthcare work and patient care.